En undersøgelse for at undersøge virkningerne af Ocrelizumab-behandling på neurofilament letkæde (NfL) niveauer og deltagertilfredshed hos deltagere med multipel sklerose (MS) (SurfSubQ)
En prospektiv longitudinel multicenter observationsundersøgelse til undersøgelse af neurofilament letkædeniveauer og patienttilfredshed efter subkutan Ocrelizumab administration hos personer med multipel sklerose
The main purpose of the study is to evaluate participant satisfaction after administration of ocrelizumab subcutaneously (SC) after 12 months using the therapy administration satisfaction questionnaire subcutaneous (TASQ-SC).
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Reference Study ID Number: ML45551 https://forpatients.roche.com/ No attachments to email below
- Telefonnummer: 888-662-6728 (U.S. Only)
- E-mail: global-roche-genentech-trials@gene.com
Undersøgelse Kontakt Backup
- Navn: Fastest response: use the inquiry form https://www.gene.com/contact-us/submit-medical-inquiry
Studiesteder
-
-
-
Bern, Schweiz, 3010
- Rekruttering
- Inselspital-Universitaetsspital Bern
-
Zurich, Schweiz, 8001
- Rekruttering
- Bellevue Medical Grop AG
-
-
-
-
-
Aachen, Tyskland, 52074
- Rekruttering
- Uniklinik RWTH Aachen
-
Amberg, Tyskland, 92224
- Rekruttering
- Gesundheitszentrum St. Marien GmbH
-
Arnsdorf, Tyskland, 01477
- Rekruttering
- Sächsisches Krankenhaus Arnsdorf
-
Aschaffenburg, Tyskland, 63739
- Rekruttering
- Neuropraxis im Stadtpalais Dres. Ulzheimer/Herröder/Wessig GbR
-
Bad Soden, Tyskland, 65812
- Rekruttering
- Neurologie Bad Soden
-
Bamberg, Tyskland, 96052
- Rekruttering
- Neurologische Praxis - Kallmann Neurologie - mszb
-
Berg, Tyskland, 82335
- Trukket tilbage
- Marianne-Strauß-klinik
-
Berlin, Tyskland, 13347
- Rekruttering
- Jüdisches Krankenhaus Berlin
-
Berlin, Tyskland, 12099
- Rekruttering
- NEUROZENTRUM tempelhof.berlin
-
Berlin, Tyskland, 10713
- Rekruttering
- Neurologisches Facharztzentrum Berlin am Sankt Gertrauden-Krankenhaus
-
Berlin, Tyskland, 12099
- Rekruttering
- Praxis Dr. Said Masri
-
Berlin, Tyskland, 14169
- Rekruttering
- NeuroZentrum Zehlendorf Dr. Ringel und Dr. Scherer
-
Berlin, Tyskland, 14195
- Rekruttering
- Neurologisches Zentrum für Bewegungsstörungen und Diagnostik
-
Bochum, Tyskland, 44791
- Rekruttering
- St. Josef-Hospital
-
Bogen, Tyskland, 94327
- Rekruttering
- Dres. Lippert/Kausch
-
Buchholz, Tyskland, 21244
- Trukket tilbage
- Krankenhaus Buchholz Abt. Neurologie
-
Celle, Tyskland, 29223
- Rekruttering
- Neuropraxis Celle: Praxis für Neurologie & Psychatrie
-
Celle, Tyskland, 29223
- Rekruttering
- Allgemeines Krankenhaus Celle / Klinik für Neurologie
-
Chemnitz, Tyskland, 09117
- Aktiv, ikke rekrutterende
- Praxisgemeinschaft Dres. Sylke Domke und Vasil Gjaurov
-
Cologne, Tyskland, 50935
- Rekruttering
- NeuroMed Campus Neurologische Gemeinschaftspraxis am St. Elisabeth Krankenhaus
-
Dortmund, Tyskland, 44137
- Trukket tilbage
- Gemeinschaftspraxis Dr. med. Josef Leclaire und Dr. med. Thomas Rotermund
-
Düsseldorf, Tyskland, 40225
- Rekruttering
- Universitätsklinikum Düsseldorf
-
Düsseldorf, Tyskland, 40211
- Rekruttering
- Gemeinschaftspraxis für Neurologie
-
Düsseldorf, Tyskland, 40625
- Trukket tilbage
- Nervenarztpraxis Gerresheim
-
Eltville, Tyskland, 65343
- Rekruttering
- Gemeinschaftspraxis für Neurologie und Psychiatrie, Psychotherapie
-
Erbach/Odenwald, Tyskland, 64711
- Rekruttering
- NeuroCentrum Odenwald
-
Erlangen, Tyskland, 91054
- Rekruttering
- Universitätsklinikum Erlangen, Neurologische Klinik
-
Essen, Tyskland, 45138
- Rekruttering
- Zentrum für ambulante Neurologie / Praxis Knorn Landefeld Friedrich
-
Essen, Tyskland, 45257
- Rekruttering
- Praxis Nervenstark
-
Forchheim, Tyskland, 91301
- Afsluttet
- Praxis für Neurologie, Nervenheilkunde & Neurochirurgie
-
Frankfurt, Tyskland, 65929
- Rekruttering
- Varisano Klinikum Frankfurt Höchst GmbH
-
Frankfurt, Tyskland, 60528
- Rekruttering
- Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie
-
Freiburg im Breisgau, Tyskland, 79106
- Rekruttering
- Universitätsklinikum Freiburg, Klinik für Neurologie und Neurophysiologie
-
Füssen, Tyskland, 87629
- Rekruttering
- Praxis im Bahnhof
-
Giessen, Tyskland, 35392
- Rekruttering
- Universitätsklinikum Gießen und Marburg GmbH
-
Gladenbach, Tyskland, 35075
- Rekruttering
- Neurologie & Psychiatrie Gladenbach - MS-Zentrum
-
Günzburg, Tyskland, 89312
- Rekruttering
- MVZ Bezirkskliniken Schwaben, Standort Günzburg
-
Halle, Tyskland, 06120
- Rekruttering
- Krankenhaus Martha-Maria Halle-Doelau
-
Hamburg, Tyskland, 20249
- Rekruttering
- Neurologische Praxis Eppendorf
-
Hamburg, Tyskland, 20246
- Rekruttering
- Universiätsklinikum Hamburg-Eppendorf
-
Hanover, Tyskland, 30171
- Rekruttering
- Neurologische Praxis
-
Hennigsdorf, Tyskland, 16761
- Rekruttering
- Oberhavel Kliniken GmbH, Klinik Hennigsdorf, Neurologie
-
Herford, Tyskland, 32052
- Rekruttering
- Praxis Dr. Hospely
-
Hettingen, Tyskland, 72513
- Rekruttering
- Haus- und Facharztzentrum Laucherttal / Alb
-
Ibbenbueren, Tyskland, 49477
- Rekruttering
- Klinikum Ibbenbüren gmbH
-
Isselburg, Tyskland, 46419
- Rekruttering
- Augustahospital Anholt;Neurologie
-
Jena, Tyskland, 07747
- Rekruttering
- Universitätsklinikum Jena, Klinik für Neurologie
-
Kiel, Tyskland, 24105
- Rekruttering
- Uniklinik Schleswig-Holstein
-
Leipzig, Tyskland, 04315
- Rekruttering
- Neurologische Praxis Dr. Ehrlich
-
Leipzig, Tyskland, 04299
- Rekruttering
- Arztpraxis Dr. med. Torsten Sühnel
-
Lübeck, Tyskland, 23538
- Rekruttering
- Universitätsklinik Schleswig Holstein, Campus Lübeck
-
Magdeburg, Tyskland, 39120
- Rekruttering
- Universitätsklinikum Magdeburg
-
Magdeburg, Tyskland, 39104
- Rekruttering
- Neurologie im Ulrichshaus Magdeburg
-
Mannheim, Tyskland, 68167
- Rekruttering
- Universitätsklinikum Mannheim
-
Mannheim, Tyskland, 68163
- Rekruttering
- Neuroplus Dres. Lennart Thilmann/ Patrick Thilmann
-
Marburg, Tyskland, 35043
- Rekruttering
- Universitätsklinikum Giessen und Marburg
-
Meerbusch, Tyskland, 40667
- Rekruttering
- Praxis Dr. Leussink
-
Minden, Tyskland, 32423
- Rekruttering
- Neurologie am Preußenmuseum
-
München, Tyskland, 81675
- Rekruttering
- Praxis für Neurologie und Psychiatrie am Prinzregentenplatz
-
München, Tyskland, 80939
- Rekruttering
- Neurologie München Nord
-
München, Tyskland, 81675
- Rekruttering
- Klinikum rechts der Isar der TU München
-
Münster, Tyskland, 48149
- Rekruttering
- Universitätsklinikum Münster
-
Münster, Tyskland, 48165
- Rekruttering
- Herz-Jesu-Krankenhaus Hiltrup GmbH
-
Neu-Ulm, Tyskland, 89231
- Rekruttering
- Neurologisch-psychiatrische Praxis im A4
-
Neuburg am Inn, Tyskland, 86633
- Rekruttering
- Praxis Dr. med. Bergmann
-
Neuruppin, Tyskland, 16816
- Rekruttering
- Ruppiner Kliniken, Hochschulklinikum der Medizinischen Hochschule Brandenburg, Klinik für Neurologie
-
Nuremberg, Tyskland, 90451
- Rekruttering
- Neurologie Nürnberg-Eibach
-
Nuremberg, Tyskland, 90419
- Rekruttering
- Gemeinschaftspraxis Uhlig und Windsheimer
-
Osnabrück, Tyskland, 49074
- Trukket tilbage
- Neurologie an der Hase
-
Pforzheim, Tyskland, 75172
- Rekruttering
- Facharztpraxis für Neurologie und Psychiatrie Dres Mattes/Stockert
-
Quakenbrück, Tyskland, 49610
- Rekruttering
- Neurologisches Studienzentrum Artland
-
Regensburg, Tyskland, 93059
- Rekruttering
- Gemeinschaftspraxis für Neurologie
-
Remscheid, Tyskland, 42853
- Rekruttering
- Gemeinschaftspraxis Dr. Stienker-Fisse & Dr. Fisse
-
Rülzheim, Tyskland, 76761
- Rekruttering
- ZNS Südpfalz
-
Schwetzingen, Tyskland, 68723
- Rekruttering
- Neurologische Praxis Dr. Wagner
-
Siegen, Tyskland, 57076
- Rekruttering
- Praxis für Neurologie und Psychiatrie
-
Siegen, Tyskland, 57072
- Rekruttering
- Gemeinschaftspraxis für Neurologie, Psychiatrie und Psychotherapie
-
Singen, Tyskland, 78224
- Rekruttering
- EMSA - Zentrum für Neurologie?/?Psychiatrie?/?Neuroradiologie
-
Sinsheim, Tyskland, 74889
- Rekruttering
- Praxis Dr. med. Max Deist und Michael Ernst ?Sinsheim
-
Steglitz, Tyskland, 12163
- Rekruttering
- Gemeinschaftspraxis Dr. Wolfram von Pannwitz, MBA & Dr. med. Marie Perle Brinckmann
-
Stuttgart, Tyskland, 70174
- Rekruttering
- Praxis Dr. med. Andreas Kowalik, Arzt für Neurologie und Psychiatrie
-
Stuttgart, Tyskland, 70176
- Rekruttering
- Neuropraxis Sotiriadis
-
Stuttgart, Tyskland, 70178
- Rekruttering
- Neurozentrum Stuttgart Mitte Sophienstraße
-
Sundern, Tyskland, 59846
- Rekruttering
- Sauerlandklinik Hachen
-
Tübingen, Tyskland, 72076
- Rekruttering
- Universitätsklinikum Tübingen, Zentrum für Neurologie
-
Ulm, Tyskland, 89078
- Rekruttering
- Nervenfachaerztliche Gemeinschaftspraxis Ulm
-
Unterhaching, Tyskland, 82008
- Rekruttering
- Neuropraxis München Süd
-
Weil der Stadt, Tyskland, 71263
- Rekruttering
- Praxis für Neurologie, Psychiatrie und Epileptologie
-
Wolfratshausen, Tyskland, 82515
- Rekruttering
- Praxis Dr. Michaela Krause
-
Zwickau, Tyskland, 08060
- Rekruttering
- Heinrich-Braun-Krankenhaus Städtisches Klinikum
-
Öhringen, Tyskland, 74613
- Rekruttering
- Dres. Beckmann / Schlüter
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Participants with relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS), diagnosed according to McDonald criteria of 2017 or revised McDonald criteria 2024, and treated with ocrelizumab SC for the first time during routine clinical practice will be observed in this study.
Beskrivelse
Inclusion Criteria:
- Diagnosis of MS
- RMS and PPMS participants diagnosed according to the McDonald criteria of 2017 or revised McDonald criteria 2024
- First treatment during the course of MS therapy with ocrelizumab SC according to the local prescribing information, regardless of the reason for starting treatment with ocrelizumab
Exclusion Criteria:
- Participation in interventional studies investigating DMTs for MS
- Prior or simultaneous participation in CONFIDENCE or MoOzaRt (ISRCTN55332718) non interventional study (NIS) at the same study site
- Prior treatment with rituximab (MabThera®) or ublituximab (Briumvi®)
- Severe psychiatric disability
- Pregnant women
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Ocrelizumab
Participants who are receiving ocrelizumab, SC injection, for the first time as part of their routine MS therapy at physician's discretion in accordance with local clinical practice and/or labeling will be observed for treatment satisfaction with SC injection for up to 12 months. |
Ocrelizumab will be administered as SC injection as per discretion of the treating physician in accordance with local clinical practice and local labeling.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of Participants by Their Level of Satisfaction With Ocrelizumab SC After 12 Months Assessed Using TASQ-SC
Tidsramme: Month 12
|
TASQ-SC is a 12-item, participant-reported questionnaire measuring the impact of treatment administration on five domains: Physical Impact, Psychological Impact, Impact on Activities of Daily Living, Convenience, and Satisfaction. Each of the domain/scale scores is scored on a scale of 1-100, where higher scores indicate higher overall satisfaction with the therapy. |
Month 12
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Koncentration af NfL-proteinniveauer i serum
Tidsramme: Baseline, måned 6, måned 12
|
Baseline, måned 6, måned 12
|
|
|
Antal deltagere efter deres niveau af tilfredshed med Ocrelizumab SC vurderet af lægeundersøgelse
Tidsramme: Baseline, måned 6, måned 12
|
Baseline, måned 6, måned 12
|
|
|
Årlig tilbagefaldsrate
Tidsramme: Måned 12
|
Måned 12
|
|
|
Procentdel af deltagere med progression uafhængig af tilbagefaldsaktivitet (PIRA)
Tidsramme: Op til måned 12
|
Op til måned 12
|
|
|
Antal deltagere med ikke-alvorlige uønskede hændelser (nsAE'er), Serious Adverse Events (SAE'er) og Adverse Events of Special Interests (AESI'er)
Tidsramme: Op til måned 12
|
Op til måned 12
|
|
|
Change From Baseline in NfL Protein Levels in Serum
Tidsramme: Baseline, Month 6, Month 12
|
Baseline, Month 6, Month 12
|
|
|
Number of Participants by Their Level of Satisfaction With Ocrelizumab SC After the First Injection and After 6 Months Assessed Using TASQ-SC
Tidsramme: Baseline, Month 6
|
TASQ-SC is a 12-item, participant-reported questionnaire measuring the impact of treatment administration on five domains: Physical Impact, Psychological Impact, Impact on Activities of Daily Living, Convenience, and Satisfaction. Each of the domain/scale scores is scored on a scale of 1-100, where higher scores indicate higher overall satisfaction with the therapy. |
Baseline, Month 6
|
|
Correlation Between NfL Protein Levels in Serum With MS Relapse
Tidsramme: Up to Month 12
|
The changes in levels of NfL protein levels in serum and its correlation with MS relapse will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With Expanded Disability Status Scale (EDSS)
Tidsramme: Up to Month 12
|
The changes in levels of NfL protein levels in serum and its correlation with EDSS will be analyzed using Pearson or Spearman correlation coefficients. EDSS is a scale for assessing neurologic impairment in MS. Values are from 0 points (normal neurological examination) up to 10 points (death), increasing in increments of 0.5 points. Higher scores represent increased disability. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With Previous MS Disease Modifying Therapy (DMT)
Tidsramme: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with DMT will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With NfL Confounder - Serum Creatinine
Tidsramme: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with serum creatinine will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With NfL Confounder - Co-morbidities
Tidsramme: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with co-morbidities will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With NfL Confounder - Age
Tidsramme: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with age will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With NfL Confounder - Body Mass Index [BMI]
Tidsramme: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with BMI will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With Magnetic Resonance Imaging (MRI) Lesion Count
Tidsramme: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with MRI lesion count will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With Glial Fibrillary Acidic Protein (GFAP) Levels
Tidsramme: Up to Month 12
|
The changes in levels of NfL protein in serum and its correlation with GFAP levels will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Correlation Between NfL Protein Levels in Serum With No Evidence of Disease Activity-3 (NEDA-3)
Tidsramme: Up to Month 12
|
NEDA-3 is defined by no confirmed MS relapse, no new or enlarging T2 lesions, no Gadolinium-positive T1 lesions, and no six-month confirmed disability worsening. The changes in levels of NfL protein in serum and its correlation with NEDA-3 will be analyzed using Pearson or Spearman correlation coefficients. |
Up to Month 12
|
|
Change From Baseline in Participant Satisfaction With Ocrelizumab SC Assessed Using Treatment Satisfaction Questionnaire for Medication (TSQM) 1.4
Tidsramme: Baseline, Month 6, Month 12
|
TSQM version 1.4 is a 14-item questionnaire used to measure level of satisfaction or dissatisfaction with the medication on 4 domains: Effectiveness, Side Effects, Convenience, and Global Satisfaction. Each of the domain is scored on likert-type scales of 5 or 7 points ranging from 1 (least satisfied) to 5 or 7 (most satisfied). Item scores are summarized to give four domain scores, which are in turn transformed to a scale of 0-100. Higher scores indicate higher overall satisfaction with the therapy. |
Baseline, Month 6, Month 12
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Studieleder: Clinical Trials, Hoffmann-La Roche
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- ML45551
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
For eligible studies, qualified researchers may request access to individual patient level clinical data. See Roche's commitment to transparency of clinical study information here: https://go.roche.com/data_sharing
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .